Form 8-K - Current report:
SEC Accession No. 0001193125-24-237196
Filing Date
2024-10-15
Accepted
2024-10-15 07:08:00
Documents
16
Period of Report
2024-10-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889682d8k.htm   iXBRL 8-K 30202
2 EX-99.1 d889682dex991.htm EX-99.1 36623
7 GRAPHIC g889682g1015040649737.jpg GRAPHIC 4479
  Complete submission text file 0001193125-24-237196.txt   239973

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clym-20241015.xsd EX-101.SCH 3207
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clym-20241015_def.xml EX-101.DEF 13738
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20241015_lab.xml EX-101.LAB 22529
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20241015_pre.xml EX-101.PRE 14554
18 EXTRACTED XBRL INSTANCE DOCUMENT d889682d8k_htm.xml XML 5505
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 241369233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)